Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Balázs Ács
Veronika Zámbó
Laura Vízkeleti
A. Marcell Szász
Lilla Madaras
Gyöngyvér Szentmártoni
Tímea Tőkés
Béla Á. Molnár
István Artúr Molnár
Stefan Vári-Kakas
Janina Kulka
Anna-Mária Tőkés
机构：
[1] Semmelweis University,2nd Department of Pathology
[2] Semmelweis University,MTA
[3] MTA-TTK Lendület Cancer Biomarker Research Group,SE
[4] Semmelweis University,NAP Brain Metastasis Research Group
[5] Semmelweis University,Department of Clinical Oncology
[6] University of Oradea,1st Department of Surgery
[7] Romania,MTA
[8] Faculty of Electrical Engineering and Information Technology,SE Tumor Progression Research Group
[9] Semmelweis University,undefined
[10] 2nd Department of Pathology,undefined
来源：
Diagnostic Pathology | / 12卷
关键词：
Breast; Neoadjuvant chemotherapy; Ki-67; Predictive and prognostic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy
    Yilmaz, Hatice
    Demirag, Guzin
    Sullu, Yurdanur
    Yilmaz, Ali
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (05): : 546 - 552
  • [42] Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Penault-Llorca, Frederique
    Abrial, Catherine
    Raoelfils, Ines
    Chollet, Philippe
    Cayre, Anne
    Mouret-Reynier, Marie-Ange
    Thivat, Emilie
    Mishellany, Florence
    Gimbergues, Pierre
    Durando, Xavier
    ONCOLOGIST, 2008, 13 (12): : 1235 - 1245
  • [43] Ki67 can be used as a predictive factor for the effectiveness of neoadjuvant chemotherapy in breast cancer patients
    Kozar, Nejc
    Lovrec, Vida Gavric
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (06) : 150 - 156
  • [44] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [45] Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
    Davey, Matthew G.
    Hynes, Sean O.
    Kerin, Michael J.
    Miller, Nicola
    Lowery, Aoife J.
    CANCERS, 2021, 13 (17)
  • [46] Predictive and prognostic value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
    Wang, R-X
    Chen, S.
    Jin, X.
    Shao, Z-M
    CANCER RESEARCH, 2017, 77
  • [47] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [48] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [49] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    EJSO, 2011, 37 (02): : 155 - 161
  • [50] Comparison of Manual Count and Image Analysis Methods in Reporting Ki-67 Index as Prognostic/Predictive Marker for Breast Cancer
    Lee, L. H.
    Bigras, G.
    Ogilvie, R. T.
    Yang, H.
    LABORATORY INVESTIGATION, 2013, 93 : 380A - 380A
12345